|
ERI1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.291800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.094000E-02 |
| Normal-vs-Stage2 |
2.268600E-01 |
| Normal-vs-Stage3 |
6.580000E-02 |
| Normal-vs-Stage4 |
2.464100E-02 |
| Stage1-vs-Stage2 |
4.358600E-03 |
| Stage1-vs-Stage3 |
9.879800E-01 |
| Stage1-vs-Stage4 |
5.962400E-01 |
| Stage2-vs-Stage3 |
1.226070E-02 |
| Stage2-vs-Stage4 |
3.464300E-03 |
| Stage3-vs-Stage4 |
6.291400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.720600E-03 |
| Normal-vs-AfricanAmerican |
1.206040E-01 |
| Normal-vs-Asian |
2.670000E-01 |
| Caucasian-vs-AfricanAmerican |
8.527200E-01 |
| Caucasian-vs-Asian |
3.598200E-01 |
| AfricanAmerican-vs-Asian |
4.306200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.482030E-01 |
| Normal-vs-Female |
2.941600E-02 |
| Male-vs-Female |
6.477000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.452130E-02 |
| Normal-vs-Age(41-60Yrs) |
1.168410E-01 |
| Normal-vs-Age(61-80Yrs) |
5.456400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.331800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.079800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.012620E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.873800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.253400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.556000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.395600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.692600E-01 |
| Classical-VS-Follicular |
<1E-12 |
| Classical-VS-Other |
1.328020E-01 |
| Classical-VS-Normal |
7.71780000000666E-05 |
| Tall-VS-Follicular |
6.58220145055566E-11 |
| Tall-VS-Other |
7.482000E-02 |
| Tall-VS-Normal |
1.856740E-03 |
| Follicular-VS-Other |
8.823600E-02 |
| Follicular-VS-Normal |
2.03829999999572E-05 |
| Other-VS-Normal |
7.622400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.987800E-01 |
| Normal-vs-N1 |
5.855700E-02 |
| N0-vs-N1 |
5.330300E-02 |
|
|
